Healthpeak Properties, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Healthpeak Properties, Inc. stock analysis DOC overview
Slightly Bullish +25

Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026

🏢 Healthpeak Properties, Inc. (NYSE: DOC), an S&P 500 real estate investment trust, declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026.

💵 The quarterly dividend totals an annualized amount of $1.22 per share for stockholders of record as of the close of business on specified dates.

📅 Dividends are payable to shareholders recorded on Friday, April 17, 2026; Thursday, April 30, 2026; Monday, June 15, 2026, and Friday, June 26, 2026.

🏥 DOC owns and operates a diversified portfolio of high-quality real estate focused on healthcare discovery and delivery across the United States.

💰 The company manages outpatient medical properties, laboratory facilities, and continuing care retirement community assets.

📉 With a market capitalization of $11.4 billion, DOC stock has decreased nearly 17% over the past 52 weeks while the S&P 500 rose by a similar margin.

⚠️ Analysts project Healthpeak to report fiscal Q1 2026 FFO as Adjusted of $0.44 per share, representing a 4.4% decline from $0.46 in the prior-year quarter.

📉 Fiscal 2026 analysts forecasts for FFO as Adjusted show a projected decrease to $1.73 per share, down nearly 6% from fiscal 2025 levels of $1.84.

📈 Conversely, full-year fiscal 2027 FFO as Adjusted is anticipated to grow 2.9% year-over-year to $1.78 per share.

📉 Shares fell 2.8% following Q4 2025 results due to weak forward guidance and 2026 Nareit FFO projections below Wall Street estimates.

⚖️ Concerns regarding the company include a drop in AFFO, plans for approximately $1 billion in asset sales, and uncertainty surrounding the Janus Living IPO.

👥 Analyst consensus on DOC stock is cautiously optimistic, with 18 analysts covering the ticker showing seven "Strong Buy," two "Moderate Buy," and nine "Hold" ratings.

🎯 The average analyst price target for Healthpeak Properties is set at $19.47, suggesting potential upside of approximately 18.5% from current trading levels.

Bullish Signals
  • Healthpeak Properties declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026, annualizing to $1.22 per share.
  • The company has surpassed or met Wall Street's bottom-line estimates in the last four quarterly reports, demonstrating consistent performance relative to analyst expectations.
  • Analysts forecast FFO as Adjusted to grow 2.9% year-over-year to $1.78 per share in fiscal 2027, indicating a positive growth trajectory ahead of current declines.
  • Among 18 analysts covering the stock, seven suggest a 'Strong Buy' rating and the average price target implies a potential upside of 18.5% from current levels.
  • Healthpeak Properties is a fully integrated REIT and S&P 500 company with a market cap of $11.4 billion, managing a diversified portfolio across outpatient medical, lab, and continuing care retirement community properties.
Risk Factors
  • Analysts project DOC's FFO as Adjusted for fiscal 2026 will decline nearly 6% to $1.73 per share, down from $1.84 in fiscal 2025, indicating potential earnings pressure despite recent revenue growth expectations.
  • The stock has decreased nearly 17% over the past 52 weeks, significantly lagging behind the broader S&P 500 Index's nearly 17% gain during the same period, suggesting investor concerns about the company's relative performance.
  • Following Q4 2025 results on Feb. 2, shares fell 2.8% due to weak forward guidance with 2026 Nareit FFO projected at $1.70 per share, which is below its 2025 level of $1.81.
  • AFFO is anticipated to drop to $0.40 from $0.44 year-over-year, raising concerns about the quality and sustainability of earnings growth.
  • Heavy capital recycling plans are underway, including approximately $1 billion in asset sales which could impact the company's portfolio stability and future growth prospects.
  • Uncertainty surrounding the Janus Living IPO adds further downside risk and potential operational distraction for Healthpeak Properties.
Full Analysis
Healthpeak Properties, Inc. (NYSE: DOC), a S&P 500 company and real estate investment trust specializing in healthcare discovery and delivery real estate, declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026 on April 6, 2026. The Board of Directors announced the quarterly payments will occur on specific dates, with record dates set to determine eligible shareholders based on the close of business prior to those payment deadlines. This monthly dividend structure results in an annualized total of $1.22 per share of common stock, reflecting the company's continued commitment to distributing returns to its investors across its diversified portfolio of outpatient medical, laboratory, and continuing care retirement community properties. Analysts project Healthpeak Properties will report fiscal first quarter 2026 funds from operations (FFO) as Adjusted of $0.44 per share, representing a 4.4% decline from the year-ago quarter's $0.46 per share. Looking further ahead, consensus forecasts for fiscal 2026 place FFO as Adjusted at $1.73 per share, down nearly 6% from the $1.84 per share reported in fiscal 2025. However, expectations are positive for fiscal 2027, with projected growth of 2.9% year-over-year to $1.78 per share. Despite recent volatility, the company has maintained a track record of surpassing or meeting Wall Street estimates in its last four quarterly reports, though shares recently faced pressure following Q4 2025 results due to guidance updates and concerns regarding capital recycling plans involving approximately $1 billion in asset sales. The stock has decreased nearly 17% over the past 52 weeks, lagging significantly behind the broader S&P 500 Index, which gained roughly 17% during the same period, while outperforming its direct competitor ETF, the State Street Real Estate Select Sector SPDR ETF, which dipped 2%. Following the announcement of weak forward guidance for fiscal 2026 and uncertainty surrounding a potential Janus Living IPO, shares fell 2.8% on February 2 after Q4 2025 results. As of now, Healthpeak Properties is valued at a market capitalization of $11.4 billion. Analyst sentiment remains cautiously optimistic with an overall "Moderate Buy" rating among the 18 analysts covering the stock; seven rate it "Strong Buy," two "Moderate Buy," and nine "Hold." The average analyst price target stands at $19.47 per share, suggesting a potential upside of 18.5% from current levels.